Unexpected high prevalence of HPV 90 infection in an underserved population

Archives of Pathology and Laboratory Medicine

Volumn 137, Issue 11, 2013, Pages 1569-1573

  Quiroga Garza, Gabriela ^a   Zhou, Haijun ^a   Mody, Dina R ^a,b   Schwartz, Mary R ^a   Ge, Yimin ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ALPHAPAPILLOMAVIRUS; CLASSIFICATION; COHORT ANALYSIS; CONFERENCE PAPER; CYTOPATHOGENIC EFFECT; FEMALE; GENETICS; GENOTYPE; HISPANIC; HUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; PREVALENCE; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VULNERABLE POPULATION; YOUNG ADULT;

ADULT; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; CYTOPATHOGENIC EFFECT, VIRAL; DNA, VIRAL; FEMALE; GENOTYPE; HISPANIC AMERICANS; HUMANS; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SEXUALLY TRANSMITTED DISEASES, VIRAL; TEXAS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VULNERABLE POPULATIONS; YOUNG ADULT;

EID: 84887844317     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2012-0640-OA     Document Type: Conference Paper

References (17)

1. Garnett GP,Waddell HC. Public health paradoxes and the epidemiological impact of an HPV vaccine. J Clin Virol. 2000;19(1-2):101-111
2. Schiffman M, Glass AG, Wentzensen N, Rush BB, Castle PE, Scott DR, et al. A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer Epidemiol Biomarkers Prev. 2011;20(7):1398-1409
3. Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, et al. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer. 2009;125(9):2151-2158
4. International Agency for Research on Cancer. Human Papillomaviruses. Vol. 100B. Lyon, France: International Agency for Research on Cancer; 2009
5. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114-2119
6. Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer. 2009;4:1-8
7. Daf S, Jena L, Kumar S. Comparative phylogenetic analysis of E6 and E7 proteins of different 42 strains of HPV. JK Sci. 2010;12(1):6-10
8. Feoli-Fonseca JC, Oligny LL, Filion M, Simard P, Russo PA, Yotov WV. JC9813-A putative novel human papillomavirus identified by PCR-DS. Biochem BiophysRes Commun. 1998;250(1):63-67
9. Klaassen CH, Prinsen CF, de Valk HA, Horrevorts AM, Jeunink MA, Thunnissen FB. DNA microarray format for detection and subtyping of human papillomavirus. J Clin Microbiol. 2004;42(5):2152-2160
10. Terai M, Burk RD. Identification and characterization of 3 novel genital human papillomaviruses by overlapping polymerase chain reaction: candHPV89, candHPV90, and candHPV91. J Infect Dis. 2002;185(12):1794-1797
11. Migaldi M, Pecorari M, Forbicini G, Nanni N, Grottola A, Grandi T, et al. Low prevalence of human papillomavirus infection in the healthy oral mucosa of a Northern Italian population. J Oral Pathol Med. 2012;41(1):16-20
12. Kovács K, Varnai AD, Bollmann M, Bankfalvi A, Szendy M, Speich N, et al. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany. J Med Virol. 2008;80(10):1814-1823
13. Chansaenroj J, Lurchachaiwong W, Termrungruanglert W, Tresukosol D, Niruthisard S, Trivijitsilp P, et al. Prevalence and genotypes of human papillomavirus among Thai women. Asian Pac J Cancer Prev. 2010;11(1):117-122
14. Dursun P, Senger SS, Arslan H, Kuscu E, Ayhan A. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis. 2009;9(191):1-6
15. Al-Awadhi R, Chehadeh W, Jaragh M, Al-Shaheen A, Sharma P, Kapila K. Distribution of human papillomavirus among women with abnormal cervical cytology in Kuwait. Diagn Cytopathol. 2013;41(2):107-114
16. Fu L, Van Doorslaer K, Chen Z, Ristriani T, Masson M, Travé G, et al. Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity. PLoS One. 2010;5(9):e12816
17. Schiffman M, Castle PE. The promise of global cervical-cancer prevention. N Engl J Med. 2005;353(20):2101-2104